ADVL 1615: A phase 1 Study of Pevonedistat (MLN4924), A Cullin Ligase Inhibitor, In Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refactory Solid Tumors

Grant

Date/time Interval

  • June 27, 2018 - June 28, 2018

    • Awarded By

    Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

    • Contributor

  • Alva, Elizabeth   Investigator  
  • Friedman M.D., Gregory   Investigator  
  • Galtarossa Xavier, Ana   Investigator  
  • Liang, Wayne   Investigator  
  • Whelan M.D., Kimberly   Investigator